Table 2 Demographic and clinical characteristics of individuals with phakic presbyopia
Description | France (N = 10) | Germany (N = 10) | USA (N = 15) | Total (N = 35) |
|---|---|---|---|---|
Participant demographic characteristics | ||||
Age | ||||
Average (range) | 55.9 (41–65) | 51.1 (40–63) | 53.6 (41–65) | 53.5 (40–65) |
Sex, n (%) | ||||
Male | 2 (20.0) | 5 (50.0) | 7 (46.7) | 14 (40.0) |
Female | 8 (80.0) | 5 (50.0) | 8 (53.3) | 21 (60.0) |
Race, n (%) | ||||
Caucasian | Not appropriate to collect in France | 7 (70.0) | 4 (26.7) | 11 (36.7) |
Black/African American | 1 (10.0) | 8 (53.3) | 9 (30.0) | |
Asian | 2 (20.0) | – | 2 (6.7) | |
Other—Hispanic | – | 3 (20.0) | 3 (8.6) | |
Missing data | 10 (100) | – | – | 10 (28.6) |
Participant self-reported severity of presbyopia, n (%) | ||||
Very severe | 1 (10.0) | 1 (10.0) | 1 (6.7) | 3 (8.6) |
Severe | 1 (10.0) | 3 (30.0) | 4 (26.7) | 8 (22.9) |
Moderate | 7 (70.0) | – | 7 (46.7) | 14 (40.0) |
Mild | 1 (10.0) | 6 (60.0) | 3 (20.0) | 10 (28.6) |
Participant self-reported myopia* | ||||
No | 5 (50.0) | 6 (60.0) | 8 (53.3) | 19 (54.3) |
Yes | 5 (50.0) | 4 (40.0) | 7 (46.7) | 16 (45.7) |
Participant clinical characteristics (reported by recruiting clinician) | ||||
Number of years since diagnosis* | ||||
Average (range) | 10.4 (0.5–20.9) | 7.3 (1–17.1) | 9.9 (0.2–34.6) | 9.3 (0.2–34.6) |
Visual acuity score, average (range)a | ||||
Left eye (decimal) | 0.92 (0.6–1.0) | 0.67 (0.5–0.8) | 0.55 (0.4–0.7) | 0.68 (0.4–1.0) |
Right eye (decimal) | 0.92 (0.6–1.0) | 0.64 (0.4–0.8) | 0.55 (0.3–1.0) | 0.68 (0.3–1.0) |
Severity of participants’ binocular DCNVA at 40 cm, n (%) | ||||
Mild | 2 (20.0) | 6 (60.0) | 5 (33.3) | 13 (37.1) |
Moderate-severe | 3 (30.0) | 4 (40.0) | 10 (66.7) | 17 (48.6) |
Information not available | 5 (50.0) | – | – | 5 (14.3) |
Severity of participants’ near ADD, n (%) | ||||
Mild | 3 (30.0) | 6 (60.0) | 5 (33.3) | 14 (40.0) |
Moderate-severe | 7 (70.0) | 4 (40.0) | 10 (66.7) | 21 (60.0) |
Clinician reported myopia/ near sightedness † | ||||
None | 6 (60.0) | 5 (50.0) | 8 (53.3) | 19 (54.3) |
Mild | 2 (20.0) | – | 2 (13.3) | 4 (11.4) |
Moderate | 1 (10.0) | – | 2 (13.3) | 3 (8.6) |
High | 1 (10.0) | – | 3 (20.0) | 4 (11.4) |
Missing data | – | 5 (50.0) | – | 5 (14.3) |
Concomitant conditions, n (%)^ | ||||
Yes: | 1 (10.0) | – | 2 (13.3) | 3 (8.6) |
Posterior detachment of the left vitreous | 1 (10.0) | – | – | 1 (2.9) |
Asthma | – | – | 1 (6.7) | 1 (2.9) |
Glaucoma | – | – | 1 (6.7) | 1 (2.9) |
Chronic obstructive pulmonary disease | – | – | 1 (6.7) | 1 (2.9) |
Current treatment for presbyopia, n (%)^ | ||||
Glasses | 7 (70.0) | 5 (50.0) | 10 (66.7) | 22 (62.9) |
Unspecified | 1/7 (14.3) | 5/5 (100) | 8/10 (80.0) | 14 (40.0) |
Single vision | 2/7 (28.6) | – | 2/10 (20.0) | 4 (11.4) |
Multifocal | 4/7 (57.1) | – | – | 4 (11.4) |
Contact lenses | – | 5 (50.0) | 1 (6.7) | 6 (17.1) |
Missing data | 3 (30.0) | – | 5 (33.3) | 8 (22.9) |